68 Results for "

MAGL

" in MedChemExpress (MCE) Product Catalog:
Products (68)

68 Results for "MAGL" in MCE Product Catalog:

  • Targets Recommended:
9
9 Publications Verification
Cat. No.: HY-15249
CAS No.: 1101854-58-3
Purity:  99.46%
Target:  

MAGL

Research Areas:  

Neurological Disease

JZL 184 is a potent, selective and irreversible MAGL inhibitor that blocks 2-Arachidonoylglycerol (2-AG) hydrolysis in brain membranes (IC50 of 8 nM). JZL 184 displays >300-fold selectivity for MAGL over FAAH .
loading...
    loading...
6
6 Cited Publications
Cat. No.: HY-117474
CAS No.: 1438416-21-7
Purity:  99.83%
Target:  

MAGL

Research Areas:  

Neurological Disease

MJN110 is an orally active and selective monoacylglycerol lipase (MAGL) inhibitor with IC50s of 9.1 nM and 2.1 nM for hMAGL and 2-arachidonoylglycerol (2-AG), respectively . MJN110 produces opioid-sparing effects and displays strong antihyperalgesic activity .
loading...
    loading...
5
5 Cited Publications
Cat. No.: HY-117771
CAS No.: 1848233-58-8
Purity:  99.30%
Target:  

DAGL

DO34 is a selective DAGL inhibitor, with an IC50 of 6 nM for DAGLα conversion of SAG to 2-AG. DO34 blocks de novo 2-AG synthesis, and suppresses tonic CB1 receptor activation. DO34 blocks depolarization-induced suppression of excitation and inhibition in the cerebellum and hippocampus. DO34 regulates feeding behavior and locomotor activity in mice. DO34 abolishes AM251-mediated enhancement of parallel fiber-evoked excitatory postsynaptic currents in cerebellar slices from MAGL global knockout mice. DO34 can be used for the research of energy balance disorder and neuroinflammation .
loading...
    loading...
4
4 Cited Publications
Cat. No.: HY-15250
CAS No.: 1210004-12-8
Purity:  99.75%
Target:  

FAAH MAGL Autophagy

Research Areas:  

Neurological Disease

JZL195 is a selective and efficacious dual fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL) inhibitor with IC50s of 2 and 4 nM, respectively .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-18977
CAS No.: 1380424-42-9
Target:  

MAGL

KML29 is an extremely selective, orally active and irreversible MAGL inhibitor, with IC50 values of 15 nM, 43 nM and 5.9 nM for mouse, rat and human MAGL, respectively. KML29 exhibits minimal cross-reactivity toward other central and peripheral serine hydrolases, including no detectable activity against FAAH .
loading...
    loading...
3
3 Cited Publications
Cat. No.: HY-12332
CAS No.: 1416133-89-5
Purity:  99.90%
Target:  

MAGL

Research Areas:  

Neurological Disease

JW 642 is a potent inhibitor of monoacylglycerol lipase (MAGL) that displays IC50 values of 7.6, 14, and 3.7 nM for inhibition of MAGL in mouse, rat, and human brain membranes, respectively.
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-117632
CAS No.: 1446817-84-0
Purity:  99.96%
Synonyms: ABX-1431
Target:  

MAGL

Research Areas:  

Neurological Disease

Elcubragistat (ABX-1431) is a highly effective, selective, orally active, and blood-brain barrier-permeable monoacylglycerol lipase (MAGL) inhibitor, with an IC50 value of 14 nM .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-108613
CAS No.: 1515855-97-6
Purity:  99.55%
Target:  

MAGL

Research Areas:  

Neurological Disease Cancer

JJKK 048 is a highly selective and potent monoacylglycerol lipase (MAGL) inhibitor with IC50 values of 214 pM, 275 pM and 363 pM for human, rat, and mouse MAGL. JJKK 048 displays low cross-reactivity with other endocannabinoid targets. JJKK 048 can be used in the research of diseases such as cancer, neurodegenerative diseases, and pain .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-119283
CAS No.: 359714-55-9
Purity:  99.58%
Synonyms: MAGL-IN-5
CAY10499 (MAGL-IN-5) is a non-selective lipase inhibitor with IC50 values of 144 nM and 14 nM for monoacylglycerol lipase (MAGL) and fatty acid amide hydrolase (FAAH), respectively. Additionally, CAY10499 exhibits anti-inflammatory and antiviral activities .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-N2512
CAS No.: 589-68-4
1-Monomyristin acts as an insecticide, enzyme inhibitor, antibacterial and antifungal agent, with an IC50 of 18 μM against rat FAAH and an IC50 of 32 μM against rat MAGL. 1-Monomyristin inhibits 2-oleoylglycerol hydrolysis via MAGL. 1-Monomyristin suppresses the growth of Staphylococcus aureus, Aggregatibacter actinomycetemcomitans and Candida albicans. 1-Monomyristin is lethal to brine shrimp . 1-Monomyristin exhibits marginal cytotoxicity against prostate cancer cells. 1-Monomyristin is applicable to research related to bacterial infections, fungal infections, renal cancer, prostate adenocarcinoma and pancreatic cancer .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-133130
CAS No.: 1252765-13-1
Purity:  99.42%
Target:  

MAGL

Research Areas:  

Neurological Disease

JNJ-42226314, a chemical probe, is a competitive, highly selective and reversible non-covalent monoacylglycerol lipase (MAGL) inhibitor. JNJ-42226314 demonstrates dose-dependent enhancement of the major endocannabinoid 2-arachidonoylglycerol (2-AG) as well as efficacy in models of neuropathic and inflammatory pain .
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-111538
CAS No.: 2324160-91-8
Purity:  99.78%
Target:  

MAGL

Research Areas:  

Cancer

MAGL-IN-1 is a potent, selective, reversible and competitive inhibitor of MAGL, with an IC50 of 80 nM. MAGL-IN-1 exhibits anti-proliferative effects against human breast, colorectal, and ovarian cancer cells. MAGL-IN-1 blocks MAGL in cell-based as well as in vivo assays .
loading...
    loading...
Cat. No.: HY-77491
CAS No.: 1010096-65-7
Target:  

FAAH MAGL

Research Areas:  

Neurological Disease

AM6701 is a potent FAAH/MAGL inhibitor (equipotent inhibitory IC50: 1.2 nM) with neuroprotective effects .
loading...
    loading...
Cat. No.: HY-132310
CAS No.: 2135785-20-3
Purity:  99.91%
Target:  

MAGL

Research Areas:  

Neurological Disease

MAGL-IN-4 is an orally active, selective and reversible monoacylglycerol lipase (MAGL) inhibitor with an IC50 of 6.2 nM. MAGL-IN-4 can penetrate the blood-brain barrier (BBB). MAGL-IN-4 enhances endocannabinoid signaling mostly by the increase in the level of 2-AG via selective MAGL inhibition in the brain .
loading...
    loading...
Cat. No.: HY-116141
CAS No.: 161180-11-6
Purity:  ≥98.0%
Synonyms: 7-HCA; Umbelliferyl Arachidonate; 7-HC-arachidonate
Target:  

Phospholipase MAGL

Research Areas:  

Others

7-Hydroxycoumarinyl arachidonate (7-HCA) is a fluorogenic substrate of cytosolic phospholipase A2 (PLA2). 7-Hydroxycoumarinyl arachidonate is also a fluorogenic substrate for monoacylglycerol lipase (MAGL). MAGL protein catalyzes the hydrolysis of 7-Hydroxycoumarinyl arachidonat to generate Arachidonic acid (AA) and the highly fluorescent 7-hydroxyl coumarin (7-HC; HY-N0573). Release of 7-HC can be measured using a fluorometer .
loading...
    loading...
Cat. No.: HY-177093
CAS No.: 2244136-58-9
Synonyms: BMS-986368; CC-97489; ABX-1772
Target:  

MAGL FAAH

Research Areas:  

Neurological Disease

Irafamdastat (BMS-986368) (Example 74) is a FAAH and MAGL inhibitor, with IC50s ≤ 100 nM (human FAAH) and 100 nM-1 μM (human MAGL) respectively. Irafamdastat has antiepileptic effect .
loading...
    loading...
Cat. No.: HY-120851
CAS No.: 1572051-31-0
Purity:  ≥95.0%
Research Areas:  

Metabolic Disease

O-7460 is a potent and selective DAGLα inhibitor, with an IC50 of 0.69 μM. O-7460 shows selectivity over onoacylglycerol lipase (MAGL), human CB1 and CB2 cannabinoid receptors. O-7460 can decrease HFD-caused an up-regulation of 2-AG levels .
loading...
    loading...
Cat. No.: HY-118158
CAS No.: 256383-45-6
Purity:  99.83%
Target:  

FAAH

Research Areas:  

Neurological Disease

FAAH/MAGL-IN-4 (Compound 13) is a potent fatty acid amide hydrolase (FAAH) and monoglyceride lipase (MGL) inhibitor with IC50s of 9.1 nM and 7.9 μM, respectively. FAAH/MAGL-IN-4 can be used for the research of pain and CNS disorders .
loading...
    loading...
Cat. No.: HY-121422
CAS No.: 1680193-80-9
Purity:  99.72%
Target:  

MAGL Histamine Receptor

Research Areas:  

Inflammation/Immunology

JZP-361 is a potent, reversible and selective inhibitor of human recombinant MAGL (hMAGL) with an IC50 of 46 nM. JZP-361 also shows antihistaminergic activities and can be used for asthma research .
loading...
    loading...
Cat. No.: HY-111512
CAS No.: 2075629-81-9
Purity:  99.31%
Target:  

MAGL

PF-06795071 is a potent and selective covalent MAGL inhibitor with an IC50 of 3 nM .
loading...
    loading...